Stock listing
MAIA Stock Price, News, Filings & Events — Maia Biotechnology, Inc.
Selected listing: MAIA · AMEX · USD · US
This page tracks Maia Biotechnology, Inc.'s MAIA:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MAIA:AMEX. MAIA:AMEX is the stock-level entry point for investors researching Maia Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maia Biotechnology, Inc. is a public company traded under the ticker MAIA in the American market. The company has a market capitalization of approximately $75.4 million. Maia focuses on developing innovative therapies in the biotechnology sector.
- Ticker
- MAIA:AMEX
- Asset type
- Stock
- Market cap
- $79.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- AMEX
- Currency
- USD
Maia Biotechnology, Inc. MAIA:AMEX stock context
This page tracks Maia Biotechnology, Inc.'s MAIA:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MAIA:AMEX. MAIA:AMEX is the stock-level entry point for investors researching Maia Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maia Biotechnology, Inc. is a public company traded under the ticker MAIA in the American market. The company has a market capitalization of approximately $75.4 million. Maia focuses on developing innovative therapies in the biotechnology sector.
Latest news from Maia Biotechnology, Inc.
MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
September 10, 2026
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion T...
July 8, 2026
MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer
June 25, 2026
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory Un...
June 18, 2026
MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial
June 4, 2026
Research Maia Biotechnology, Inc.
Maia Biotechnology, Inc. investor report
Review AI stock analysis and investor report context for MAIA:AMEX.
Maia Biotechnology, Inc. company profile
View the public company page for Maia Biotechnology, Inc. on 6ix.
Maia Biotechnology, Inc. news
Read company news and market updates connected to Maia Biotechnology, Inc..
Maia Biotechnology, Inc. investor events
Find investor webinars, events, and replay context for Maia Biotechnology, Inc..